Neuros Life Sciences

💊 Neuropharmaceuticals· 📍 San Diego, CA

Overview

Neuros Life Sciences develops small-molecule therapeutics targeting neuroinflammation pathways to treat Alzheimer's disease and related dementias.

Cortexyme Inc.

San Francisco, CA, USA

Neuralstem Inc.

Germantown, MD, USA

Neurogenix Therapeutics

Basel, Switzerland

Acadia Pharmaceuticals

San Diego, USA

Acer Therapeutics

Newton, MA, USA

Praxis Precision Medicine

Cambridge, MA, USA

Brain Implant Uses Infrared Light to Bypass Electrode Limitations in Neural Signaling

2026-08-23 · Research

BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years

2026-08-06 · Product

Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge

2026-08-05 · Industry

Smaller Neuromodulation Devices Are Reshaping the Competitive Landscape for TMS Providers

2026-08-04 · Industry

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Advertise

Newsletter sponsorships, featured listings, and sponsored articles.